Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: An NCCN Institutional Analysis

Restricted access

Background

The National Comprehensive Cancer Network (NCCN) Outcomes Database was created to assess concordance to evidence- and consensus-based guidelines and to measure adherence to quality measures on an ongoing basis. The Colorectal Cancer Database began in 2005 as a collaboration among 8 NCCN centers.

Methods

Newly diagnosed colon and rectal cancer patients presenting to 1 of 8 NCCN centers between September 1, 2005, and May 21, 2008, were eligible for analysis of concordance with NCCN treatment guidelines for colorectal cancer and with a set of quality metrics jointly developed by ASCO and NCCN in 2007. Adherence rates were determined for each metric. Center-specific rates were benchmarked against mean concordance rates for all participating centers.

Results

A total of 3443 patients were evaluable. Mean concordance rates with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures were generally high (≥ 90%). However, relatively low mean concordance rates were noted for adjuvant chemotherapy treatment recommendations within 9 months of diagnosis of stage II to III rectal cancer (81%), and neoadjuvant chemoradiation in clinical T4 rectal primaries (83%). These low rates of concordance seemed to be consistent across centers.

Conclusions

Adherence to guidelines and quality measures is generally high at institutions participating in the NCCN colorectal cancer database. Lack of documentation, patient refusal, delayed treatment initiation, and lack of consensus about whether treatment was essential were the primary reasons for nonconcordance. Measurement of concordance and the reasons for nonconcordance enable participating centers to understand and improve their care delivery systems.

Correspondence: Deborah Schrag, MD, Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, SM 204, Boston, MA 02115. E-mail: deb_schrag@dfci.harvard.edu
  • 1

    HerdmanRMcGuireWSimoneJ. Influencing Cancer Policy. Tracing the influence of an Institute of Medicine effort to improve the quality of cancer care. Health Affairs2006;25:800807.

    • Search Google Scholar
    • Export Citation
  • 2

    HewittMSimoneJV. Ensuring Quality Cancer Care. Washington, D.C.: National Academy Press; 1999: 211225.

  • 3

    LipscombJGotayCCSnyderC. Outcomes Assessment in Cancer. Measures Methods and Applications. New York: Cambridge University Press; 2005.

    • Search Google Scholar
    • Export Citation
  • 4

    MalinJLSchneiderECEpsteinAM. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?J Clin Oncol2006;244:626634.

    • Search Google Scholar
    • Export Citation
  • 5

    American Cancer Society. American Cancer Society Extramural Grants Programs in Effect September 1 1998. Atlanta: American Cancer Society; 1998.

    • Search Google Scholar
    • Export Citation
  • 6

    American Society of Clinical Oncology. The Quality Oncology Practice Initiative. Available at: http://qopi.asco.org. Accessed July 22 2009.

    • Search Google Scholar
    • Export Citation
  • 7

    National Cancer Institute. Cancer Topics: Colon and Rectal Cancer. Available at: http://www.cancer.gov/cancertopics/types/colon-and-rectal. Accessed July 22 2009.

    • Search Google Scholar
    • Export Citation
  • 8

    Cancer Trends Progress Report – 2007 Update. National Cancer Institute NIH DHHS Bethesda MD December 2007. Available at: http://progressreport.cancer.gov. Accessed July 22 2009.

    • Search Google Scholar
    • Export Citation
  • 9

    SchragD. The price tag on progress—chemotherapy for colorectal cancer. N Engl J Med2004;351:317319.

  • 10

    EngstromPFArnolettiJPBensonAB. The NCCN Clinical Practice Guidelines in Oncology: Colon Cancer version 2 2009. Available at: http://www.nccn.org/professionals/physician_gls/PDF/colon.pdf. Accessed July 23 2009.

    • Search Google Scholar
    • Export Citation
  • 11

    EngstromPFArnolettiJPBensonAB. The NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer version 2 2009. Available at: http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf. Accessed July 23 2009.

    • Search Google Scholar
    • Export Citation
  • 12

    ASCO/NCCN Quality Measures: Breast and Colorectal Cancers. Press Release. Available at: http://www.nccn.org/professionals/quality_measures/default.asp. Accessed July 22 2009.

    • Search Google Scholar
    • Export Citation
  • 13

    CharlsonMEPompeiPAlesKLMacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987;40:373383.

    • Search Google Scholar
    • Export Citation
  • 14

    RiesLAGMelbertDKrapchoM eds. SEER Cancer Statistics Review 1975–2005. National Cancer Institute. Bethesda MD. Available at: http://seer.cancer.gov/csr/1975_2005/. Accessed July 22 2009.

    • Search Google Scholar
    • Export Citation
  • 15

    HassettMJHughesMNilandJ. Selecting high priority quality measures for breast cancer quality improvement. Med Care2008;46:762770.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 203 203 51
PDF Downloads 90 90 20
EPUB Downloads 0 0 0